Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$6.17 - $10.65 $86,700 - $149,653
14,052 New
14,052 $119,000
Q2 2023

Aug 14, 2023

BUY
$2.6 - $3.34 $129,831 - $166,782
49,935 Added 11.92%
469,002 $1.27 Million
Q1 2023

May 15, 2023

BUY
$2.56 - $3.55 $626,155 - $868,301
244,592 Added 140.19%
419,067 $1.25 Million
Q4 2022

Feb 14, 2023

SELL
$1.5 - $4.82 $348,429 - $1.12 Million
-232,286 Reduced 57.11%
174,475 $440,000
Q3 2022

Nov 14, 2022

BUY
$1.75 - $3.44 $140,054 - $275,306
80,031 Added 24.49%
406,761 $740,000
Q2 2022

Aug 15, 2022

BUY
$3.15 - $7.94 $392,751 - $989,983
124,683 Added 61.71%
326,730 $1.03 Million
Q1 2022

May 16, 2022

BUY
$6.18 - $14.44 $410,951 - $960,216
66,497 Added 49.06%
202,047 $1.25 Million
Q4 2021

Feb 14, 2022

SELL
$7.8 - $14.38 $882,468 - $1.63 Million
-113,137 Reduced 45.49%
135,550 $1.93 Million
Q3 2021

Nov 15, 2021

BUY
$7.76 - $29.37 $1.76 Million - $6.65 Million
226,369 Added 1014.29%
248,687 $1.99 Million
Q2 2021

Aug 16, 2021

SELL
$24.17 - $34.28 $426,624 - $605,076
-17,651 Reduced 44.16%
22,318 $638,000
Q1 2021

May 17, 2021

SELL
$11.61 - $32.08 $9,288 - $25,664
-800 Reduced 1.96%
39,969 $1.16 Million
Q4 2020

Feb 16, 2021

SELL
$5.47 - $12.1 $121,472 - $268,704
-22,207 Reduced 35.26%
40,769 $486,000
Q3 2020

Nov 16, 2020

BUY
$6.0 - $7.79 $377,856 - $490,583
62,976 New
62,976 $435,000

Others Institutions Holding EPIX

About ESSA Pharma Inc.


  • Ticker EPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,073,100
  • Market Cap $80.7M
  • Description
  • ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...
More about EPIX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.